These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2579873)

  • 1. PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity.
    Hof RP
    Gen Pharmacol; 1985; 16(1):1-6. PubMed ID: 2579873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation.
    Hof RP; Hof A
    Basic Res Cardiol; 1985; 80(1):66-75. PubMed ID: 3985926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits.
    Hof RP
    Br J Pharmacol; 1985 May; 85(1):75-87. PubMed ID: 4027474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats.
    Hof RP
    Br J Pharmacol; 1984 May; 82(1):51-60. PubMed ID: 6733358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo.
    Hof RP; Scholtysik G
    J Cardiovasc Pharmacol; 1983; 5(2):176-83. PubMed ID: 6188886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine.
    Hof RP; Hof A; Neumann P
    J Cardiovasc Pharmacol; 1982; 4(3):352-62. PubMed ID: 6177929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.
    Hof RP
    Br J Pharmacol; 1983 Feb; 78(2):375-94. PubMed ID: 6831117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular properties of LF 2.0254, a new potent vasoselective calcium channel blocker with a slow onset of action.
    Pruneau D; Roy F; Brown NL
    Fundam Clin Pharmacol; 1990; 4(2):223-43. PubMed ID: 2112508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of S-312, a new calcium antagonist, on the mechanical and electrophysiological responses of isolated cardiovascular preparations.
    Ninomiya M; Tani T; Nakajima S; Ueda M
    Jpn J Pharmacol; 1989 Oct; 51(2):227-38. PubMed ID: 2593380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: comparison with other calcium antagonists.
    Kanda A; Haruno A; Miyoshi K; Tanahashi Y; Miyake H; Ichihara K; Okumura K; Nagasaka M
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):167-75. PubMed ID: 7690090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
    Motomura S; Hashimoto K
    Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the vasoconstrictor effects of noradrenaline and serotonin by the selective calcium antagonist PY 108-068 in the peripheral circulation of anesthetized cats.
    Hof RP; Hof A; Kalkman HO
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S53-60. PubMed ID: 2414596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity.
    Nagura J; Murayama B; Harada N; Suzuki K; Miyano T; Yajima M; Takeya K
    Jpn J Pharmacol; 1986 Mar; 40(3):399-409. PubMed ID: 3712868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of FR34235, a new dihydropyridine slow channel blocker, in isolated rabbit myocardium and aorta.
    Furuta T; Shibata S; Kodama I; Yamada K
    J Cardiovasc Pharmacol; 1983; 5(5):836-41. PubMed ID: 6195473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
    Nakaya H; Hattori Y; Tohse N; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
    Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
    Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.